MKS Instruments(US:MKSI) Globenewswire·2025-02-12 21:30Core Insights - MKS Instruments reported strong financial results for Q4 and full year 2024, with revenue and adjusted EBITDA exceeding the midpoint of guidance, indicating robust performance despite mixed demand conditions [2][3][7] - The company is well-positioned for 2025, driven by increased customer engagement in its optics solutions and solid trends in its chemistry business, highlighting its critical role in advanced electronics [2][3] Financial Performance - Q4 2024 revenue reached $935 million, up from $896 million in Q3 2024 and $893 million in Q4 2023, while full year revenue totaled $3.586 billion, slightly down from $3.622 billion in 2023 [9] - GAAP net income for Q4 2024 was $90 million, translating to a diluted earnings per share of $1.33, compared to $62 million and $0.92 per share in Q3 2024 [9][7] - Adjusted EBITDA for Q4 2024 was $237 million, with non-GAAP net earnings per diluted share at $2.15, both figures above the midpoint of guidance [7][9] Guidance for Q1 2025 - The company anticipates Q1 2025 revenue of $910 million, plus or minus $40 million, with GAAP net income projected at $43 million, plus or minus $19 million, and adjusted EBITDA expected to be $217 million, plus or minus $23 million [4] Operational Highlights - MKS Instruments maintained a healthy gross margin of 47.2% in Q4 2024, slightly down from 48.2% in Q3 2024, while the operating margin improved to 14.5% from 14.3% [9][30] - The company successfully managed its leverage, completing a repricing of its term loan B and making a voluntary principal prepayment of $100 million in January 2025 [3][12] Cash Flow and Capital Structure - As of December 31, 2024, MKS had $714 million in cash and cash equivalents, with total liabilities amounting to $6.268 billion [11][21] - The company paid a cash dividend of $15 million in Q4 2024, maintaining a consistent dividend policy [11]